UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 189

Sortiert nach

PSMA Theranostics: Current Status and Future Directions

Molecular Imaging, 2018-01, Vol.17, p.1536012118776068-1536012118776068

2018

Link zum Volltext

Verfügbarkeit prüfen

Deep neural network for automatic characterization of lesions on 68Ga-PSMA-11 PET/CT

European journal of nuclear medicine and molecular imaging, 2020-03, Vol.47 (3), p.603-613

2020

Link zum Volltext

Verfügbarkeit prüfen

A comprehensive review of imaging findings in COVID-19 - status in early 2021

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (8), p.2500-2524

2021

Link zum Volltext

Verfügbarkeit prüfen

Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Journal of the American Heart Association, 2023-08, Vol.12 (16), p.e030271-e030271

2023

Link zum Volltext

Verfügbarkeit prüfen

The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer

Journal of Nuclear Medicine, 2016-10, Vol.57 (Suppl 3), p.79S-89S

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT

European journal of nuclear medicine and molecular imaging, 2021-07, Vol.48 (8), p.2395-2404

2021

Link zum Volltext

Verfügbarkeit prüfen

EARL compliance measurements on the biograph vision Quadra PET/CT system with a long axial field of view

EJNMMI physics, 2022-04, Vol.9 (1), p.26-26, Article 26

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis

European journal of nuclear medicine and molecular imaging, 2021-08, Vol.48 (9), p.2978-2989

2021

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic accuracy of [18F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer

European journal of nuclear medicine and molecular imaging, 2022-06, Vol.49 (7), p.2436-2444

2022

Link zum Volltext

Verfügbarkeit prüfen

Digital versus analogue PET in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer: a matched-pair comparison

European journal of nuclear medicine and molecular imaging, 2020-03, Vol.47 (3), p.614-623

2020

Link zum Volltext

Verfügbarkeit prüfen

The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions

Journal of Nuclear Medicine, 2015-11, Vol.56 (11), p.1697-1705

2015

Link zum Volltext

Verfügbarkeit prüfen

Performance of [68Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy—a multi-centre evaluation of 2533 patients

European journal of nuclear medicine and molecular imaging, 2021-08, Vol.48 (9), p.2925-2934

2021

Link zum Volltext

Verfügbarkeit prüfen

Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging

European journal of nuclear medicine and molecular imaging, 2017-11, Vol.44 (12), p.2117-2136

2017

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of late acquisition [68Ga]Ga-PSMA-11 PET/CT using a long axial field-of-view PET/CT scanner for the diagnosis of recurrent prostate cancer—first clinical experiences

European journal of nuclear medicine and molecular imaging, 2021-12, Vol.48 (13), p.4456-4462

2021

Link zum Volltext

Verfügbarkeit prüfen

A randomised, prospective and head-to-head comparison of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 for the detection of recurrent prostate cancer in PSMA-ligand PET/CT—Protocol design and rationale

PloS one, 2022-07, Vol.17 (7), p.e0270269-e0270269

2022

Link zum Volltext

Verfügbarkeit prüfen

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer

Pharmaceuticals (Basel, Switzerland), 2014-06, Vol.7 (7), p.779-796

2014

Link zum Volltext

Verfügbarkeit prüfen

The influence of digital PET/CT on diagnostic certainty and interrater reliability in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer

European radiology, 2021-10, Vol.31 (10), p.8030-8039

2021

Link zum Volltext

Verfügbarkeit prüfen

The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia

European journal of nuclear medicine and molecular imaging, 2020-03, Vol.47 (3), p.642-651

2020

Link zum Volltext

Verfügbarkeit prüfen

Added value of 68Ga-PSMA PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer and a previous 99mTc bone scintigraphy

EJNMMI research, 2020-04, Vol.10 (1), p.31-31, Article 31

2020

Link zum Volltext

Verfügbarkeit prüfen

New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress

Pharmaceuticals (Basel, Switzerland), 2021-10, Vol.14 (10), p.1023

2021

Link zum Volltext

Verfügbarkeit prüfen

Radiolabeled PSMA Inhibitors

Cancers, 2021-12, Vol.13 (24), p.6255

2021

Link zum Volltext

Verfügbarkeit prüfen

Incidental SARS-CoV-2-related findings in asymptomatic patients in [18F]-FDG-PET/CT—potential insights

European journal of nuclear medicine and molecular imaging, 2020-08, Vol.47 (9), p.2068-2069

2020

Link zum Volltext

Verfügbarkeit prüfen

Effect of the versatile bifunctional chelator AAZTA5 on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonist

EJNMMI radiopharmacy and chemistry, 2020-11, Vol.5 (1), p.29-29, Article 29

2020

Link zum Volltext

Verfügbarkeit prüfen

Long-axial field-of-view PET/CT: perspectives and review of a revolutionary development in nuclear medicine based on clinical experience in over 7000 patients

Cancer imaging, 2023-03, Vol.23 (1), p.28-28, Article 28

2023

Link zum Volltext

Verfügbarkeit prüfen

Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer

Seminars in nuclear medicine, 2016-09, Vol.46 (5), p.405-418

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 189

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(174)
Mit Volltextzugriff
(168)

Publikationsform

Sprache

Englisch
(184)
Japanisch
(12)
Deutsch
(6)

Erscheinungsjahr

n.n

Thema

Prostate Cancer
(77)
Humans
(75)
Science & Technology
(66)
Life Sciences & Biomedicine
(62)
Nuclear Medicine
(62)
Oncology
(60)
Male
(59)
Imaging
(58)
Medicine
(58)
Medicine & Public Health
(58)
Radiology
(57)
Orthopedics
(53)
Radiology, Nuclear Medicine & Medical Imaging
(51)
Cardiology
(50)
Tomography
(40)
Computed Tomography
(39)
Positron Emission
(39)
Prostatic Neoplasms - Diagnostic Imaging
(38)
Original Article
(36)
Psma
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

PSMA Theranostics: Current Status and Future Directions

Deep neural network for automatic characterization of lesions on 68Ga-PSMA-11 PET/CT

A comprehensive review of imaging findings in COVID-19 - status in early 2021

Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer

Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT

EARL compliance measurements on the biograph vision Quadra PET/CT system with a long axial field of view

Comparing the diagnostic performance of radiotracers in recurrent prostate cancer: a systematic review and network meta-analysis

Diagnostic accuracy of [18F]PSMA-1007 PET/CT in biochemical recurrence of prostate cancer

Digital versus analogue PET in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer: a matched-pair comparison

The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions

Performance of [68Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy—a multi-centre evaluation of 2533 patients

Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging

Feasibility of late acquisition [68Ga]Ga-PSMA-11 PET/CT using a long axial field-of-view PET/CT scanner for the diagnosis of recurrent prostate cancer—first clinical experiences

A randomised, prospective and head-to-head comparison of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 for the detection of recurrent prostate cancer in PSMA-ligand PET/CT—Protocol design and rationale

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer

The influence of digital PET/CT on diagnostic certainty and interrater reliability in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer

The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia

Added value of 68Ga-PSMA PET/CT for the detection of bone metastases in patients with newly diagnosed prostate cancer and a previous 99mTc bone scintigraphy

New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress

Radiolabeled PSMA Inhibitors

Incidental SARS-CoV-2-related findings in asymptomatic patients in [18F]-FDG-PET/CT—potential insights

Effect of the versatile bifunctional chelator AAZTA5 on the radiometal labelling properties and the in vitro performance of a gastrin releasing peptide receptor antagonist

Long-axial field-of-view PET/CT: perspectives and review of a revolutionary development in nuclear medicine based on clinical experience in over 7000 patients

Current Status of Prostate-Specific Membrane Antigen Targeting in Nuclear Medicine: Clinical Translation of Chelator Containing Prostate-Specific Membrane Antigen Ligands Into Diagnostics and Therapy for Prostate Cancer

Suchergebnisse filtern